Electrodes For Medical Devices Market Analysis By Type {Diagnostics (ECG, EEG, EMG, ERG, Fetal Scalp), Therapeutics (Pacemaker, TENS, Defibrillator, Electrosurgical)}, By Region, And Segment Forecasts, 2014 - 2025

The global electrodes for medical devices market is expected to reach USD 2.0 billion by 2025, according to a new report by Grand View Research, Inc. The market is anticipated to witness lucrative growth during the forecast period, owing to increasing prevalence of chronic and other diseases such as heart diseases, Parkinson’s Disease (PD), Alzheimer’s disease, brain disorders, Trigeminal Neuralgia (TN or TGN), sinusitis, tinnitus, Raynaud's disease, fibromyalgia, circulatory disturbances, gout, and body ache, across the globe.
Minimally Invasive Surgery (MIS) is one of the advancements in medical technology in which small incisions are made in the body for laparoscopy, endoscopy, arthroscopy, and other surgical procedures. This procedure is gaining popularity owing to faster recovery, lesser postsurgical infections, pain, & major bleeding, reduced scarring, and high accuracy benefits. In 2015, over 20.0 million Americans underwent MIS, which is expected to assist in the growth of this vertical during the forecast period.
Further Key Findings From the Study Suggest:
‧ The diagnostic segment held a profitable revenue share in 2016 and is expected to grow at a significant rate over the forecast period.
‧ Rising prevalence of heart diseases, fetal distress syndrome, ocular diseases, and neurological disorders make extensive use of Electrocardiogram (ECG), Electroencephalogram (EEG), electrosurgical, and fetal scalp electrodes
‧ The therapeutic segment is anticipated to witness the fastest growth over the forecast period due to widened use of medical electrodes in aesthetic surgeries, RF ablation procedures, neurosurgical procedures, and acute & chronic pain treatments
‧ Defibrillator and electrosurgical electrodes are projected to hold substantial market share over the forecast period. This can be attributed to the advanced development of wearable defibrillator that constantly monitors the cardiac rhythms of the wearer and identifies & notifies the user about the occurrence of any abnormality and helps regain the normal heart functionality
‧ North America is expected to dominate the medical electrodes market during the forecast period, owing to the rising prevalence of CVDs, changing lifestyle of individuals, and presence of target population in the U.S. and Canada. In addition, the presence of advanced technologies with electrodes such as hydrogel and dry electrodes in the region are expected to spur the medical electrodes market growth.
‧ Some of the key players in medical electrodes market are 3M Healthcare; Boston Scientific Corporation; GE Healthcare; C.R Bard Inc.; CONMED Corporation; Medtronic; Natus Medical Incorporated; Thermo Fisher Scientific Inc.; Asahi Kasei Corporation; and Philips Healthcare

Table of Contents
Chapter 1. Methodology and Scope
1.1. Information Procurement
1.1.1. Purchased database
1.1.2. GVR’s internal database
1.2. Data Analysis
1.3. Market Formulation & Validation
1.4. Primary Research
1.4.1. List of primary sources
1.5. Approaches for Market Estimation
1.5.1. Approach 1: Commodity flow & bottom-up approach
1.5.2. Approach 2: Top-down and parent market analysis
Chapter 2. Executive Summary
2.1. Market Snapshot, 2016
Chapter 3. Medical Electrodes Market Variables, Trends & Scope
3.1. Market Segmentation & Scope
3.2. Market Size & Growth prospects
3.3. Market Driver Analysis
3.4. Market Restraint Analysis
3.5. Penetration & Growth Prospect Mapping
3.6. SWOT Analysis, by Factor
3.6.1. Political
3.6.2. Economic
3.6.3. Technological
3.7. Industry Analysis - Porter’s
Chapter 4. Medical Electrodes Market: Type Estimates & Trend Analysis
4.1. Type Movement Analysis & Market Share, 2016 & 2025
4.2. Market Size Estimates & Forecasts and Trend Analyses, 2014 - 2025 for the following type:
4.2.1. Diagnostics
4.2.1.1. Electrocardiogram (ECG)
4.2.1.1.1. ECG market estimates and forecasts, 2014 - 2025
4.2.1.2. Electroencephalogram (EEG)
4.2.1.2.1. EEG market estimates and forecasts, 2014 - 2025
4.2.1.3. Electromyogram (EMG)
4.2.1.3.1. EMG market estimates and forecasts, 2014 - 2025
4.2.1.4. Electroretinogram (ERG)
4.2.1.4.1. ERG market estimates and forecasts, 2014 - 2025
4.2.1.5. Fetal Scalp
4.2.1.5.1. Fetal scalp market estimates and forecasts, 2014 - 2025
4.2.1.6. Other
4.2.1.6.1. Other market estimates and forecasts, 2014 - 2025
4.2.2. Therapeutics
4.2.2.1. Pacemaker
4.2.2.1.1. Pacemaker market estimates and forecasts, 2014 - 2025
4.2.2.2. Transcutaneous Electrical Nerve Stimulator (TENS)
4.2.2.2.1. TENS market estimates and forecasts, 2014 - 2025
4.2.2.3. Defibrillator
4.2.2.3.1. Defibrillator market estimates and forecasts, 2014 - 2025
4.2.2.4. Electrosurgical
4.2.2.4.1. Electrosurgical market estimates and forecasts, 2014 - 2025
4.2.2.5. Other
4.2.2.5.1. Other market estimates and forecasts, 2014 - 2025
Chapter 5. Medical Electrodes Market: Regional Estimates & Trend Analysis
5.1. Regional Movement Analysis & Market Share, 2016 & 2025
5.2. North America
5.2.1. U.S.
5.2.1.1. U.S. revenue estimates and forecasts, by type (USD Million) 2014 - 2025
5.2.2. Canada
5.2.2.1. Canada revenue estimates and forecasts, by type (USD Million) 2014 - 2025
5.3. Europe
5.3.1. UK
5.3.1.1. UK revenue estimates and forecasts, by type (USD Million) 2014 - 2025
5.3.2. Germany
5.3.2.1. Germany revenue estimates and forecasts, by type (USD Million) 2014 - 2025
5.4. Asia Pacific
5.4.1. Japan
5.4.1.1. Japan revenue estimates and forecasts, by type (USD Million) 2014 - 2025
5.4.2. China
5.4.2.1. China revenue estimates and forecasts, by type (USD Million) 2014 - 2025
5.5. Latin America
5.5.1. Brazil
5.5.1.1. Brazil revenue estimates and forecasts, by type (USD Million) 2014 - 2025
5.5.2. Mexico
5.5.2.1. Mexico revenue estimates and forecasts, by type (USD Million) 2014 - 2025
5.6. MEA
5.6.1. South Africa
5.6.1.1. South Africa revenue estimates and forecasts, by type (USD Million) 2014 - 2025
Chapter 6. Competitive Landscape
6.1. Strategy Framework
6.2. Company Profiles
6.2.1. 3M Healthcare
6.2.1.1. Company overview
6.2.1.2. Financial performance
6.2.1.3. Product benchmarking
6.2.2. Boston Scientific Corporation
6.2.2.1. Company overview
6.2.2.2. Financial performance
6.2.2.3. Product benchmarking
6.2.2.4. Strategic initiatives
6.2.3. GE Healthcare
6.2.3.1. Company overview
6.2.3.2. Financial performance
6.2.3.3. Product benchmarking
6.2.4. C.R Bard Inc.
6.2.4.1. Company overview
6.2.4.2. Financial performance
6.2.4.3. Product benchmarking
6.2.4.4. Strategic initiatives
6.2.5. CONMED
6.2.5.1. Company overview
6.2.5.2. Financial Performance
6.2.5.3. Product benchmarking
6.2.5.4. Strategic initiatives
6.2.6. Medtronic
6.2.6.1. Company overview
6.2.6.2. Financial performance
6.2.6.3. Product benchmarking
6.2.6.4. Strategic initiatives
6.2.7. Natus Medical Incorporated
6.2.7.1. Company overview
6.2.7.2. Financial Performance
6.2.7.3. Product benchmarking
6.2.7.4. Strategic initiatives
6.2.8. Thermo Fisher Scientific Inc.
6.2.8.1. Company overview
6.2.8.2. Financial performance
6.2.8.3. Product benchmarking
6.2.8.4. Strategic initiatives
6.2.9. Asahi Kasei Corporation
6.2.9.1. Company overview
6.2.9.2. Financial performance
6.2.9.3. Product benchmarking
6.2.9.4. Strategic initiatives
6.2.10. Philips Healthcare
6.2.10.1. Company overview
6.2.10.2. Financial performance
6.2.10.3. Product benchmarking
6.2.10.4. Strategic initiatives